Polypharmacy in Psychiatry
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Refractoriness to treatment, in turn, lends itself to the use of switching and/ or augmenting strategies, which, as the Sequenced Treatment Alternatives to Relieve Depression Study (STAR*D) teaches [60], may propel depressive illness into a phase characterized by low remission, high relapse, and high intolerance to medications [48].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [60]
Citations
Cites
Still being checked.
Cited by
National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry
Mojtabai, R., & Olfson, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.175 · Cited by 479
Patterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders
Baldessarini, R. J., Leahy, L., Arcona, S., Gause, D., Zhang, W., & Hennen, J. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.1.85 · Cited by 280
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Centorrino, F., Goren, J. L., Hennen, J., Salvatore, P., Kelleher, J. P., & Baldessarini, R. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.700 · Cited by 253
Comer, J. S., Olfson, M., & Mojtabai, R. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.07.007 · Cited by 252
Factors associated with treatment nonadherence among US bipolar disorder patients
Baldessarini, R. J., Perry, R., & Pike, J. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.908 · Cited by 198
KATSCHNIG, H. (2010) · World Psychiatry · doi:10.1002/j.2051-5545.2010.tb00257.x · Cited by 187
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review
Fornaro, M., De Berardis, D., Koshy, A., Perna, G., Vancampfort, D., Stubbs, B., & Valchera, A. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s100846 · Cited by 115
Iatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Discontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava, G. A., & Belaise, C. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000492693 · Cited by 77
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Zhu, B., Ascher‐Svanum, H., Faries, D. E., Correll, C. U., & Kane, J. M. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-19 · Cited by 66
Medicine and psychiatry in Western culture: Ancient Greek myths and modern prejudices
Fornaro, M., Clementi, N., & Fornaro, P. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-21 · Cited by 59
Nosologomania: DSM & Karl Jaspers' Critique of Kraepelin
Ghaemi, S. N. (2009) · Philosophy, Ethics, and Humanities in Medicine · doi:10.1186/1747-5341-4-10 · Cited by 48
Self-citationCompliance: the impact of adverse events and tolerability on the physician’s treatment decisions
Roose, S. P. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00097-x · Cited by 54
Toward a Hippocratic Psychopharmacology
Ghaemi, S. N. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805300309 · Cited by 45
Self-citationEmerging Treatments for Bipolar Disorder: Safety and Adverse Effect Profiles
Marken, P. A., & Pies, R. W. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g112 · Cited by 45
Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data
Bauer, M., Glenn, T., Alda, M., Sagduyu, K., Marsh, W., Grof, P., MUNOZ, R. A., Severus, E., Ritter, P. S., & Whybrow, P. C. (2013) · International Journal of Bipolar Disorders · doi:10.1186/2194-7511-1-5 · Cited by 43
The Definition and Prevalence of Pediatric Psychotropic Polypharmacy
Chen, H., Patel, A., Sherer, J. T., & Aparasu, R. R. (2011) · Psychiatric Services · doi:10.1176/appi.ps.000642011 · Cited by 41
Teamwork: The Therapeutic Alliance in Pediatric Pharmacotherapy
Joshi, S. V. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.08.004 · Cited by 40
Use of combinations of antipsychotics: McLean Hospital inpatients, 2002
Centorrino, F., Fogarty, K. V., Sani, G., Salvatore, P., Cincotta, S. L., Hennen, J. A., Guzzetta, F., Talamo, A., Saadeh, M. G., & Baldessarini, R. J. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.719 · Cited by 40
Hospital use of antipsychotic drugs: polytherapy
Centorrino, F., Cincotta, S. L., Talamo, A., Fogarty, K. V., Guzzetta, F., Saadeh, M., Salvatore, P., & Baldessarini, R. J. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2007.08.002 · Cited by 38
Artin, H., Bentley, S., Mehaffey, E., Liu, F. X., Sojourner, K., Bismark, A. W., Printz, D., Lee, E., Martis, B., Peralta, S. D., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101439 · Cited by 41
Combining Lithium and Anticonvulsants in Bipolar Disorder: A Review
Pies, R. W. (2002) · Annals of Clinical Psychiatry · doi:10.1023/a:1021969001231 · Cited by 32
Effectiveness of quetiapine in rapid cycling bipolar disorder: A preliminary study
Goldberg, J. F., Kelley, M. E., Rosenquist, K. J., Hsu, D. J., Filkowski, M. M., & Ghaemi, S. N. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.04.023 · Cited by 27
Self-citationAli, Z., Ismail, M., Nazar, Z., Khan, F., Khan, Q., & Noor, S. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02687-w · Cited by 27
Cuevas, C. D. L., Peñate, W., de Cecilia, J. M. G., & de León, J. (2017) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2017.11.003 · Cited by 24
Motivational Interviewing and Adolescent Psychopharmacology
Jellinek, M. S., Henderson, S. W., DiLallo, J., & Weiss, G. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181930660 · Cited by 19
Use of polypharmacy and self-reported mood in outpatients with bipolar disorder
Adli, M., Whybrow, P. C., Grof, P., Rasgon, N., Gyulai, L., Baethge, C., Glenn, T., & Bauer, M. (2005) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500510029200 · Cited by 19
International prescribing patterns for mood illness: The international mood network (IMN)
Mauer, S., Alahmari, R., Vöhringer, P. A., Vergne, D. E., Lövdahl, H., Correa, E., Patkar, A. A., Pae, C., Strejilevich, S., Dalley, S., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.049 · Cited by 17
Self-citationPolypharmazie in der Behandlung der Schizophrenie
Messer, T., Tiltscher, C., & Schmauß, M. (2009) · Springer eBooks · doi:10.1007/978-3-211-79826-3_2 · Cited by 15
Psychiatric Polypharmacy: A Clinical Approach Based on Etiology and Differential Diagnosis
Freudenreich, O., Kontos, N. J., & Querques, J. (2012) · Harvard Review of Psychiatry · doi:10.3109/10673229.2012.677358 · Cited by 15
Atik, L., Erdoğan, A., Karaahmet, E., Saraçlı, Ö., Atasoy, N., Kurçer, M. A., & Balcıoğlu, İ. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.12.031 · Cited by 12
Augmentation Treatment with Amisulpride in Schizophrenic Patients Partially Responsive to Olanzapine
Molina, J. D. D., Toledo-Romero, F., López-Rodríguez, E., Amorin-Díaz, M., Lerma-Carrillo, I., & Lopez-Munoz, F. J. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1279728 · Cited by 12
Pediatric Bipolar Disorder: Part I — Is it related to classical Bipolar
Littrell, J. L., & Lyons, P. (2010) · Children and Youth Services Review · doi:10.1016/j.childyouth.2010.03.020 · Cited by 11
De l’usage rationnel à l’usage optimal des médicaments psychotropes auprès des enfants
Lafortune, D., Gagné, M., & Blais, É. (2011) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2011.05.002 · Cited by 11
Wróblewski, K., Petruczynik, A., & Waksmundzka‐Hajnos, M. (2017) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2017.1284675 · Cited by 10
Pediatric Bipolar Disorder: An issue for Child Welfare
Littrell, J. L., & Lyons, P. (2010) · Children and Youth Services Review · doi:10.1016/j.childyouth.2010.03.021 · Cited by 10
Bauer, M., Glenn, T., Grof, P., Rasgon, N., Marsh, W., Sagduyu, K., Alda, M., Lewitzka, U., Schmid, R., & Whybrow, P. C. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500802450514 · Cited by 6
Mirabzadeh, A., Bakhshi, E., Khodae, M. R., Kooshesh, M. R., Mahabadi, B. R., Mirabzadeh, H., & Biglarian, A. (2013) · PubMed Central · Cited by 5
Nurses opinion on the attributes of polypharmacy in patient safety.
Jenny, J. L., Cheriathu, J., Sreedharan, J., Muttappallymyalil, J., Arifulla, M., Arun, S., & Mohamed, F. M. (2012) · PubMed · Cited by 4
Mirabzadeh, A., Khodaei, M. R., & Shemshadi, H. (2015) · European Psychiatry · doi:10.1016/s0924-9338(15)31100-7 · Cited by 3
Mirabzadeh, A., Shemshadi, H., Ardakani, M. R. K., Sadighi, G., Hashempour, S., Mirabzadeh, H., & Biglarian, A. (2014) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20140701043605 · Cited by 2
Principles & Practice of Polypharmacotherapy
Howland, R. H. (2006) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20060301-05 · Cited by 1
Sozańska, A., Nogły, J., Mierzwińska-Mucha, J., Roś, B., & Siekaniec, K. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.82.60516 · Cited by 1
Kombinationen von Psychopharmaka
Messer, T., Tiltscher, C., & Schmauß, M. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_11 · Cited by 1
Pattern of Psychotropic Drug Prescription in the Elderly with Chronic Schizophrenia
Reza, K. M., Mirabzadeh, A., Shemshadi, H., Zabihollah, A., Ranjbar, M., Golnaz, F., Samiei, M., & Alireza, K. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Antipsychotic Polypharmacy in Czech Republic and in Ukraine
Самохвалов, В. П., Samokhvalova, O., Вербенко, В. А., & Verbenko, G. N. (2012) · Springer eBooks · doi:10.1007/978-94-007-5799-8_3
Creativity in psychopharmacotherapy - the bright side of face of psychiatric god Janus.
Damjanović, A. (2015) · PubMed
Management commentary: What would Hippocrates do?
Ghaemi, S. N. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.028
Self-citationPolypharmacy in Clinical Psychiatry - A Brief Review
Singh, G. (2021) · Eastern Journal of Psychiatry · doi:10.5005/ejp-13-1--2-72
Metadata
- Authors
- Ghaemi, S. N.
- Corresponding author
- Ghaemi, S. Nassir
- ORCID
- Ghaemi, S. Nassir
- Venue
- CRC Press eBooks
- Publisher
- CRC Press
- Published
- 2002-05-06
- OpenAlex
- W2499989446
- Cited by
- 48
- References
- 0
- Citations by year
- 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 3
- Type
- reference entry
- Language
- en
- Open access
- closed
- Locations
- CRC Press eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- polypharmacy, psychiatric medication, antipsychotic drugs, antidepressants, adverse drug reactions, drug safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.